Covered recipient · General Payments record
ASHLEY MUSGROVE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$401.41
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $401.41 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $140.24 | 11 |
| Acerta Pharma LLC | $91.27 | 5 |
| Lilly USA, LLC | $82.61 | 5 |
| Phathom Pharmaceuticals, Inc. | $34.39 | 2 |
| DEXCOM, INC. | $18.85 | 1 |
| Seqirus USA Inc | $17.63 | 1 |
| Novo Nordisk AS | $16.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $401.41 | 26 |
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.37 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713199 | CMS |
| ABBVIE INC. | $17.14 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713201 | CMS |
| ABBVIE INC. | $11.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713203 | CMS |
| ABBVIE INC. | $13.35 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713205 | CMS |
| ABBVIE INC. | $10.41 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713207 | CMS |
| ABBVIE INC. | $10.61 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713209 | CMS |
| ABBVIE INC. | $17.22 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713211 | CMS |
| ABBVIE INC. | $15.83 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713213 | CMS |
| ABBVIE INC. | $14.08 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713215 | CMS |
| ABBVIE INC. | $17.20 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713217 | CMS |
| ABBVIE INC. | $1.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107713219 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.39 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104689730 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.08 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105320940 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.60 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105572123 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.99 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104602548 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.21 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104743895 | CMS |
| Dexcom, Inc. | $18.85 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153350064 | CMS |
| Lilly USA, LLC | $24.32 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135559730 | CMS |
| Lilly USA, LLC | $13.57 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135563832 | CMS |
| Lilly USA, LLC | $14.04 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135593772 | CMS |
| Lilly USA, LLC | $16.67 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135578888 | CMS |
| Lilly USA, LLC | $14.01 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135551559 | CMS |
| Novo Nordisk Inc | $16.42 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268544 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.07 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151191769 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151191771 | CMS |
| Seqirus USA Inc | $17.63 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125636771 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.